Browse by Nurse Practitioner Items

Nurse practitioner PBS prescribing

MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS

From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners) Information for nurse practitioners to become authorised PBS prescribers is available from the Department of Human Services.

The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.

PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.

The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.

Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:

  • Continuing therapy only model

Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)

  • Shared care model

Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.

Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.

Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.

Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms.  For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms.  Nurse practitioner PBS prescriptions may include repeats. 

Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.

Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from the Department of Human Services for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)

State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

  • Legend
  • MPMedical Practitioner
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 8133C VALACICLOVIRvalaciclovir 500 mg tablet, 10 2 20 0
MPNP 5480K VALACICLOVIRvalaciclovir 500 mg tablet, 30 1 30 5
MPNP 8134D VALACICLOVIRvalaciclovir 500 mg tablet, 30 1 30 5
MPNP 8064K VALACICLOVIRvalaciclovir 500 mg tablet, 42 1 42 0
MPNP 9135T VALINE WITH CARBOHYDRATEvaline with carbohydrate containing 50 mg valine oral liquid: powder for, 30 x 4 g sachets 4 4 5
MPNP 9434M VALINE WITH CARBOHYDRATEvaline with carbohydrate containing 1 g valine oral liquid: powder for, 30 x 4 g sachets 4 4 5
MPNP 2294R VALPROATEvalproate sodium 100 mg tablet, 100 2 200 2
MPNP 2290M VALPROATEvalproate sodium 500 mg enteric tablet, 100 2 200 2
MPNP 2293Q VALPROATEvalproate sodium 200 mg/5 mL oral liquid, 300 mL 2 2 2
MPNP 2295T VALPROATEvalproate sodium 200 mg/5 mL oral liquid, 300 mL 2 2 2
MPNP 2289L VALPROATEvalproate sodium 200 mg enteric tablet, 100 2 200 2
MPNP 9370E VALSARTANvalsartan 160 mg tablet, 28 1 28 5
MPNP 9371F VALSARTANvalsartan 320 mg tablet, 28 1 28 5
MPNP 9369D VALSARTANvalsartan 80 mg tablet, 28 1 28 5
MPNP 9368C VALSARTANvalsartan 40 mg tablet, 28 1 28 0
MPNP 9372G VALSARTAN + HYDROCHLOROTHIAZIDEvalsartan 80 mg + hydrochlorothiazide 12.5 mg tablet, 28 1 28 5
MPNP 9482C VALSARTAN + HYDROCHLOROTHIAZIDEvalsartan 320 mg + hydrochlorothiazide 25 mg tablet, 28 1 28 5
MPNP 9374J VALSARTAN + HYDROCHLOROTHIAZIDEvalsartan 160 mg + hydrochlorothiazide 25 mg tablet, 28 1 28 5
MPNP 9481B VALSARTAN + HYDROCHLOROTHIAZIDEvalsartan 320 mg + hydrochlorothiazide 12.5 mg tablet, 28 1 28 5
MPNP 9373H VALSARTAN + HYDROCHLOROTHIAZIDEvalsartan 160 mg + hydrochlorothiazide 12.5 mg tablet, 28 1 28 5
MPNP 9128K VARENICLINEvarenicline 500 microgram tablet [11 tablets] (&) varenicline 1 mg tablet [42 tablets], 53 1 1 0
MPNP 5469W VARENICLINEvarenicline 1 mg tablet, 56 1 56 2
MPNP 9129L VARENICLINEvarenicline 1 mg tablet, 56 2 112 0
MPNP 8868R VENLAFAXINEvenlafaxine 37.5 mg modified release capsule, 28 1 28 0
MPNP 8302Y VENLAFAXINEvenlafaxine 150 mg modified release capsule, 28 1 28 5
MPNP 8301X VENLAFAXINEvenlafaxine 75 mg modified release capsule, 28 1 28 5
MPNP 1241H VERAPAMILverapamil hydrochloride 240 mg modified release tablet, 30 1 30 5
MPNP 2208F VERAPAMILverapamil hydrochloride 180 mg modified release tablet, 30 1 30 5
MPNP 1250T VERAPAMILverapamil hydrochloride 80 mg tablet, 100 1 100 5
MPNP 1248Q VERAPAMILverapamil hydrochloride 40 mg tablet, 100 1 100 5
MPNP 2667J VIGABATRINvigabatrin 500 mg tablet, 100 1 100 5
MPNP 2668K VIGABATRINvigabatrin 500 mg powder for oral liquid, 60 sachets 1 60 5
MPNP 3415R VILDAGLIPTINvildagliptin 50 mg tablet, 60 1 60 5
MPNP 5474D VILDAGLIPTIN + METFORMINvildagliptin 50 mg + metformin hydrochloride 500 mg tablet, 60 1 60 5
MPNP 5476F VILDAGLIPTIN + METFORMINvildagliptin 50 mg + metformin hydrochloride 1 g tablet, 60 1 60 5
MPNP 5475E VILDAGLIPTIN + METFORMINvildagliptin 50 mg + metformin hydrochloride 850 mg tablet, 60 1 60 5
MPNP 11200L VITAMINS, MINERALS AND TRACE ELEMENTSvitamins, minerals and trace elements powder for oral liquid, 30 x 7 g sachets 1 1 5
MPNP 10149E VITAMINS, MINERALS AND TRACE ELEMENTS WITH CARBOHYDRATEvitamins, minerals and trace elements with carbohydrate powder for oral liquid, 30 x 6 g sachets 1 1 5
MPNP 9328Y VITAMINS, MINERALS AND TRACE ELEMENTS WITH CARBOHYDRATEvitamins, minerals and trace elements with carbohydrate powder for oral liquid, 200 g 6 6 5
MPNP 10168E VORICONAZOLEvoriconazole 40 mg/mL powder for oral liquid, 70 mL 1 1 0
MPNP 9452L VORICONAZOLEvoriconazole 40 mg/mL powder for oral liquid, 70 mL 1 1 0
MPNP 10198R VORICONAZOLEvoriconazole 200 mg tablet, 56 1 56 0
MPNP 9364W VORICONAZOLEvoriconazole 200 mg tablet, 56 1 56 2
MPNP 10173K VORICONAZOLEvoriconazole 50 mg tablet, 56 1 56 0
MPNP 9363T VORICONAZOLEvoriconazole 50 mg tablet, 56 1 56 2